Cubist Systematic Strategies, LLC Halozyme Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $4.94 Million - $6.16 Million	146,817 Added 85.12%	319,296 $13 Million
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $667,766 - $843,726	-20,041 Reduced 10.41%	172,479 $6.37 Million
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $5.52 Million - $6.67 Million	151,415 Added 368.36%	192,520 $7.35 Million
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $1.04 Million - $1.34 Million	34,487 Added 521.11%	41,105 $1.48 Million
Q1 2023 May 15, 2023	SELL	$32.86 - $55.7 $1.28 Million - $2.17 Million	-38,930 Reduced 85.47%	6,618 $252,000
Q4 2022 Feb 14, 2023	BUY	$40.06 - $59.44 $1.82 Million - $2.71 Million	45,539 Added 505988.88%	45,548 $2.59 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $7.8 Million - $10.5 Million	-202,346 Reduced 100.0%	9 $0
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $5.98 Million - $7.74 Million	160,175 Added 379.74%	202,355 $8.9 Million
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $848,771 - $1.09 Million	26,549 Added 169.85%	42,180 $1.68 Million
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $1.86 Million - $2.39 Million	-58,588 Reduced 78.94%	15,631 $629,000
Q3 2021 Nov 15, 2021	SELL	$38.47 - $46.42 $1.98 Million - $2.39 Million	-51,423 Reduced 40.93%	74,219 $3.02 Million
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $1.62 Million - $2.14 Million	41,614 Added 49.52%	125,642 $5.71 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $2.8 Million - $3.64 Million	-70,744 Reduced 45.71%	84,028 $3.5 Million
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $2.49 Million - $4.21 Million	96,546 Added 165.81%	154,772 $6.61 Million
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $1.86 Million - $2.14 Million	-72,146 Reduced 55.34%	58,226 $1.53 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $1.07 Million - $1.76 Million	65,752 Added 101.75%	130,372 $3.5 Million
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $2.71 Million - $4.26 Million	-194,936 Reduced 75.1%	64,620 $1.16 Million
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $3.65 Million - $4.77 Million	244,185 Added 1588.61%	259,556 $4.6 Million
Q3 2019 Nov 14, 2019	SELL	$15.2 - $17.69 $287,416 - $334,500	-18,909 Reduced 55.16%	15,371 $238,000
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $335,252 - $392,302	22,729 Added 196.77%	34,280 $589,000
Q1 2019 May 15, 2019	BUY	$13.94 - $17.58 $161,020 - $203,066	11,551 New	11,551 $186,000
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $200,189 - $280,235	-15,018 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $122,231 - $134,908	-7,328 Reduced 32.79%	15,018 $273,000
Q2 2018 Aug 14, 2018	BUY	$16.87 - $20.3 $154,090 - $185,420	9,134 Added 69.13%	22,346 $377,000
Q1 2018 May 15, 2018	SELL	$17.06 - $21.2 $223,110 - $277,253	-13,078 Reduced 49.75%	13,212 $259,000
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $233,696 - $290,201	13,952 Added 113.08%	26,290 $533,000
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $145,094 - $214,681	12,338	12,338 $214,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$831 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$608 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$313 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$192 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$161 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account